Relationship Graph Explorer
Follow the connections
Every herb, ingredient, formula, gene target, and disease — connected through real research. Search, pick a subject, and navigate the graph in any direction.
🌿
Herb
6,826
→
⚗️
Ingredient
44,595
→
🧬
Gene Target
15,505
→
🏥
Disease
30,170
→
🧪
Evidence
23,295
trials · metas · refs
Plus 6,743 TCM formulas connecting herbs together
🏥 Disease / Health Topic
Peritoneal Neoplasms
9
Clinical Trials
0
Meta-Analyses
0
PubMed References
📋 Sample Trials
NCT00382811
OVATURE (OVArian TUmor REsponse) A Phase III Study of Weekly Carboplatin With and Without Phenoxodiol in Patients With Platinum-Resistant, Recurrent Epithelial Ovarian Cancer
Completed · Phase 3
NCT01015118
LUME-Ovar 1: Nintedanib (BIBF 1120) or Placebo in Combination With Paclitaxel and Carboplatin in First Line Treatment of Ovarian Cancer
Completed · Phase 3
NCT03038100
A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Completed · Phase 3
📊 Sample Meta-Analyses
None linked yet.
📚 Sample References
None linked yet.
🏥 All Disease / Health Topic data fields for Peritoneal Neoplasms
🏥 Names
Disease Name
Peritoneal Neoplasms
Alias Names
Peritoneal Surface Malignancy; Peritoneal Neoplasms
Topic Type
group
🧬 Ontology Classifications
DisGeNET Type
group
UMLS Type
Neoplastic Process
MeSH Class
Digestive System Diseases; Neoplasms
🔗 External References
🔍 Raw view — every non-empty column on this row (23 fields)
name
Peritoneal Neoplasms
alias name
Peritoneal Surface Malignancy; Peritoneal Neoplasms
topic type
group
disgenet disease type
group
umls disease type
Neoplastic Process
mesh disease class
Digestive System Diseases; Neoplasms
umls disease type id
T191
mesh disease class id
C04; C06
herb disease id
HBDIS002367
disgenet id
C0031149
mesh id
D010534
📋 Clinical Trials
9 · subject of clinical studyNCT00382811 OVATURE (OVArian TUmor REsponse) A Phase III Study of Weekly Carboplatin With an
→ Fallopian Tube Cancer|Peritoneal Neoplasms|Ovarian
NCT01015118 LUME-Ovar 1: Nintedanib (BIBF 1120) or Placebo in Combination With Paclitaxel an
→ Ovarian Neoplasms|Peritoneal Neoplasms
NCT03038100 A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplat
→ Ovarian Cancer|Fallopian Tube Cancer|Peritoneal Ne
NCT00063401 Phase II Study in Patients With Epidermal Growth Factor Receptor (EGFR) + Advanc
→ Ovarian Cancer|Peritoneal Neoplasms|Fallopian Tube
NCT00191646 An Ovarian, Primary Peritoneal or Fallopian Tube Cancer Study for Patients That
→ Genital Neoplasms, Female|Fallopian Tube Neoplasms
NCT00517621 Use of FACT-GOG/NTX Questionnaire in Peripheral Neurotoxicity & Validation of a
→ Ovarian Cancer|Fallopian Tube Cancer|Peritoneal Ne
NCT01462890 Evaluation of Optimal Treatment Duration of Bevacizumab Combination With Standar
→ Genital Diseases, Female|Ovarian Diseases|Ovarian
NCT04498117 Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovari
→ Carcinoma, Ovarian Epithelial|Ovarian Neoplasms|Ov
NCT05185947 Study of Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Perit
→ Gynecologic Cancer|Gynecologic Neoplasms|Peritonea
How relationships are computed
- Clinical Trials / Meta-Analyses / References: direct foreign-key link via
subject_entity_id(Phase 2d wireup) - Formula ↔ Herbs: text bridge via
formulas.herbs_in_pinyinmatchingherbs.pinyin_name - Herb ↔ Ingredient:
empty — needs
HERB_herb_ingredientimport - Ingredient ↔ Target:
empty — needs
HERB_ingredient_targetimport - Target ↔ Disease:
empty — needs
HERB_target_diseaseimport - Herb → Target → Disease (full chemical spine): awaiting Phase 2e link tables